The UAE Has Withdrawn These 3 Types of Blood Pressure Tablets

Three brands of blood pressure tablets have been removed from the shelves of UAE pharmacies.

Their removal follows evidence that the three brands of blood pressure tablets in the UAE market contain carcinogenic properties.

As a result, the ministry has issued circulars against the three brands, which are suspected of causing cancer.

SEE ALSO: Mandatory approval is needed to bring personal medicines into the UAE

According to circulars No. 3603 and No. 2604 issued by Dr. Amin Hussein Al Amiri, the ministry's assistant undersecretary for public health policy and licensing, the following medicines have been withdrawn:

• Arbitense 50 and 100mg, manufactured by Abu Dhabi-based company Neopharma LLC
• Amopress 5mg
• Hetlosar 50 and 100mg, manufacutred by Nexen Pharma

All medicines were registered with the Department of Health, but have since been withdrawn due to a request from the manufacture to remove supplies from the public and private sector.

Pharmacies have also been instructed to return all batches of the drug back to the supplier.

SEE ALSO: A visitor's guide to bringing medicine into the UAE

The ministry has also instructed the withdrawal of a US-manufactured defibrillator that failed to provide an electric current when in us.

The defibrillator ZOLL LifeVest 400, manufactured by the US company Zoll, has been banned by the UAE ministry for failing to monitor the patient's heartbeat and unable to provide an electric current to restore the patient's heart beat to a normal rhythm when needed.